Private: Gallery Post #1

25

Sep2020
At PDCI Market Access Inc., our vision at PDCI is to be your most trusted and valued pricing and reimbursement strategic partner. To ensure we continue to meet the strategic needs of our customers in the face of the ever-changing Canadian reimbursement landscape, we’ve expanded our Health Economic ... Read More

09

Sep2020
The August 2020 issue of Cell & Gene Therapy Insights, has a focus on Market access: evolving commercialization trends and strategies.  PDCI Market Access’ very own Neil Palmer is featured as a guest editor and the author of the article, Under construction: roadmaps for HTA, pricing and ... Read More

09

Sep2020
Palmer-Cell-and-Gene-Theraoy-InsightsDownload

19

Aug2020
PDCI is pleased to announce the release of the 2020 update to the PDCI Census of Insurers. The PDCI Census of Insurers is available exclusively through the PDCI Market Access Toolkit.  PDCI’s Census of Insurers estimates the market share and private covered lives by insurer across ... Read More

04

Aug2020
In June 2020, PMPRB launched a public consultation on its new draft Guidelines as a next step towards implementing the recently amended Patented Medicines Regulations. The deadline to submit written feedback is today,August 4, 2020. Details on submitting a consultation response can be found on the PMPRB ... Read More

15

Jul2020
PDCI PMPRB Guidelines Webinar July 22, 2020 between 10:30 am – 12:00 pmIN ADVANCE, PLEASE SUBMIT ANY QUESTIONS YOU WOULD LIKE US TO ADDRESS Please Register here.

13

Jul2020
ALERT! PMPRB WEBINAR RESCHEDULED Given all the new information this week, as well as the consultation extension, PDCI is postponing its PMPRB webinar.  Our second free webinar for industry will now be held on July 22, 2020 between 10:30 am – 12:00 ... Read More

07

Jul2020
PDCI Market Access Inc. is pleased to share its best practices infographic focused on Requesting Reconsideration under the Canadian Agency for Drugs and Technologies in Health (CADTH) Procedures for the Common Drug Review (CDR). While optional and only appropriate in select circumstances, manufacturers should not overlook this potential opportunity ... Read More

02

Jul2020
Request-for-Reconsideration-To-CADTHDownload

30

Jun2020
Yesterday, the Federal Court of Canada released its decision in the judicial review challenging the validity of the Regulations Amending the Patented Medicines Regulations that were published in Canada Gazette Part II on August 21, 2019. The judgement and reasons in Innovative ... Read More